IGM Biosciences, Inc.
General ticker "IGMS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $454.4M (TTM average)
IGM Biosciences, Inc. follows the US Stock Market performance with the rate: 1.3%.
Estimated limits based on current volatility of 4.3%: low 1.13$, high 1.24$
Factors to consider:
- Current price 74.0% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.16$, 11.75$]
- 2025-12-31 to 2026-12-31 estimated range: [3.29$, 9.49$]
Financial Metrics affecting the IGMS estimates:
- Negative: Non-GAAP EPS, $ of -3.24 <= 0.05
- Negative: Operating cash flow per share per price, % of -22.71 <= 1.99
- Negative: Shareholder equity ratio, % of 18.13 <= 21.94
- Negative: negative Net income
- Negative: Operating profit margin, % of -98.73 <= 0.04
- Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
- Negative: -0.32 < Industry inventory ratio change (median), % of 0
Short-term IGMS quotes
Long-term IGMS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.07MM | $2.13MM | $2.68MM |
| Operating Expenses | $229.03MM | $265.59MM | $211.26MM |
| Operating Income | $-227.96MM | $-263.46MM | $-208.58MM |
| Non-Operating Income | $6.85MM | $17.72MM | $12.79MM |
| R&D Expense | $179.29MM | $215.52MM | $160.85MM |
| Income(Loss) | $-221.10MM | $-245.74MM | $-195.79MM |
| Taxes | $0.00MM | $0.68MM | $0.00MM |
| Profit(Loss)* | $-214.25MM | $-246.42MM | $-195.79MM |
| Stockholders Equity | $287.26MM | $203.23MM | $48.17MM |
| Assets | $513.50MM | $423.41MM | $265.71MM |
| Operating Cash Flow | $-5.85MM | $-192.23MM | $-153.00MM |
| Capital expenditure | $10.21MM | $12.38MM | $5.85MM |
| Investing Cash Flow | $-225.64MM | $68.36MM | $64.16MM |
| Financing Cash Flow | $219.38MM | $115.07MM | $2.39MM |
| Earnings Per Share** | $-5.16 | $-4.71 | $-3.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.